Description

Gliutazon Tablets 45 mg. №28

Composition:

Each tablet contains 45 mg of Gliutazon.

Mechanism of Action:

Gliutazon acts as an agonist for peroxisome proliferator-activated receptor gamma (PPAR-γ), contributing to improved glucose and lipid metabolism. By activating PPAR-γ, Gliutazon enhances insulin sensitivity in peripheral tissues, reduces hepatic glucose production, and increases glucose uptake in skeletal muscles.

Pharmacological Properties:

Gliutazon, a thiazolidinedione, effectively improves insulin sensitivity, controls blood sugar levels, and enhances glucose utilization in the body.

Indications for Use:

Gliutazon tablets are indicated for the treatment of type 2 diabetes mellitus. They aid in managing blood glucose levels and enhancing insulin sensitivity.

Contraindications:

Avoid Gliutazon tablets if there is a history of liver disease or heart failure. Consult a healthcare provider before initiating treatment.

Side Effects:

Common side effects may include abdominal pain, dark urine, or jaundice. Regular monitoring of liver function tests is crucial due to the potential risk of liver toxicity.

Usage Instructions:

Take one tablet orally daily, with or without food, at the same time each day. Adhere to the instructions provided by your healthcare provider.

Benefits Compared to Analogues:

Gliutazon has been shown to effectively lower blood sugar levels and reduce HbA1c levels in patients with type 2 diabetes, offering improved glycemic control and reduced risk of diabetic complications compared to other oral antidiabetic agents.

Suitable Patient Groups:

Gliutazon is suitable for adult patients with type 2 diabetes mellitus. Dosage adjustments may be necessary for elderly individuals or those with renal impairment.

Storage and Shelf Life:

Store Gliutazon tablets in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use the product beyond that date.

Packaging Description:

Gliutazon tablets are available in a pack of 28 tablets, each containing 45 mg of the active ingredient. The packaging is designed to ensure the integrity and safety of the tablets.

Clinical Evidence and Proven Effectiveness:

Gliutazon has demonstrated efficacy in improving insulin sensitivity and reducing fasting plasma glucose levels in patients with type 2 diabetes. A study published in Diabetes Care highlighted the superior effects of Gliutazon compared to other antidiabetic agents, emphasizing its value in inadequately controlled diabetes cases.